Literature DB >> 15175027

Health-related quality of life and hand eczema--a comparison of two instruments, including factor analysis.

Lena-Marie Wallenhammar1, Mats Nyfjäll, Magnus Lindberg, Birgitta Meding.   

Abstract

Hand eczema is a disease of long duration, affecting the individual and society. The purpose of this study of 100 patients (51 females and 49 males) at an occupational dermatology clinic was to investigate whether the generic questionnaire Short Form-36 (SF-36), and the dermatology-specific Dermatology Life Quality Index (DLQI) are appropriate for assessing health-related quality of life (HRQL) in patients with hand eczema, and whether gender differences in HRQL could be detected. HRQL was affected by hand eczema, measured with both SF-36 and DLQI. The SF-36 showed more impaired HRQL for females than for males, in the mental health dimension, whereas no gender-related differences were detected with the DLQI. To compare the instruments we used factor analysis, with a polychoric correlation matrix as input, thus taking the ordinal aspect of the data into account. There was a high correlation between the instruments for physical health, but lower for mental health. In this context our interpretation of the factor analysis is that the SF-36 measures mental health better than the DLQI. The SF-36 therefore appears suitable for use in future studies for measuring HRQL, and gender differences in HRQL, in persons with reported hand eczema.

Entities:  

Mesh:

Year:  2004        PMID: 15175027     DOI: 10.1111/j.0022-202X.2004.22604.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.

Authors:  Daniel Condie; Daniel Grabell; Heidi Jacobe
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

2.  An imaging roadmap for biology education: from nanoparticles to whole organisms.

Authors:  Daniel J Kelley; Richard J Davidson; David L Nelson
Journal:  CBE Life Sci Educ       Date:  2008       Impact factor: 3.325

3.  [Therapy of hand eczema. What can we learn from the published clinical studies?].

Authors:  T L Diepgen; A Svensson; P J Coenraads
Journal:  Hautarzt       Date:  2005-03       Impact factor: 0.751

4.  A randomised controlled intervention study on prevention of work related skin problems among gut cleaners in swine slaughterhouses.

Authors:  M-A Flyvholm; K Mygind; L Sell; A Jensen; K F Jepsen
Journal:  Occup Environ Med       Date:  2005-09       Impact factor: 4.402

5.  Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective.

Authors:  Patricia R Blank; Armin A Blank; Thomas D Szucs
Journal:  BMC Dermatol       Date:  2010-06-25

Review 6.  [Chronic hand eczema: epidemiology and therapeutic evidence].

Authors:  T L Diepgen
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

7.  Impact of hand eczema severity on quality of life.

Authors:  Ujwala Priya Charan; C V Dincy Peter; Susanne A Pulimood
Journal:  Indian Dermatol Online J       Date:  2013-04

8.  Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial.

Authors:  Kristina Sophie Ibler; Gregor B E Jemec; Thomas L Diepgen; Christian Gluud; Jane Lindschou Hansen; Per Winkel; Simon Francis Thomsen; Tove Agner
Journal:  BMJ       Date:  2012-12-12

9.  A review of the impact of occupational contact dermatitis on quality of life.

Authors:  Melisa Yi Zhi Lau; John Anthony Burgess; Rosemary Nixon; Shyamali C Dharmage; Melanie Claire Matheson
Journal:  J Allergy (Cairo)       Date:  2011-03-16

10.  Interventions for hand eczema.

Authors:  Wietske Andrea Christoffers; Pieter-Jan Coenraads; Åke Svensson; Thomas L Diepgen; Janine L Dickinson-Blok; Jun Xia; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.